Trial Information
Prevention of Cancer by Intervention With Selenium - A Pilot Study in a Danish Population
Inclusion Criteria:
- WHO performance status 0 or 1
- No active liver- or kidney disease (Serum ALAT (alanine aminotransferase), alkalic
phosphatase, bilirubin, creatinin or urea within 2 S.D of laboratory reference range)
- No previous cancer diagnosis
- No known HIV-infection
- Participant must understand oral and written information
- Participant must not use selenium supplementation of above 50 mcg/d
- Participant must give written consent prior to inclusion
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention
Outcome Measure:
Viability of full scale study
Outcome Description:
At five years intervention (last participant last visit was june 2004) viability of full scale study was assessed according to the drop out rate, cost etc. of this pilot study.
Outcome Time Frame:
At five years intervention
Safety Issue:
No
Authority:
Denmark: Danish Health and Medicines Authority
Study ID:
OUH-DK-PILOT-PRECISE
NCT ID:
NCT01819649
Start Date:
November 1998
Completion Date:
June 2004
Related Keywords:
- Cancer
- selenium
- selenium supplementation
- randomised controlled trial
- prevention